Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-24 @ 10:51 PM
NCT ID:
NCT07163169
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 65 years or older.
* Histologically confirmed cancer diagnosis with a pre-planned chemotherapy regimen (adjuvant, neoadjuvant, or palliative intent).
* Chemotherapy not yet initiated at the time of enrollment.
* Clinically stable condition, as assessed by the oncologist.
* Willingness and ability to provide written informed consent.
Exclusion Criteria:
* Presence of acute infection or advanced organ failure (cardiac, hepatic, or renal).
* Severe psychiatric illness or cognitive impairment that interferes with the ability to complete assessments.
* Patients receiving concurrent hormonal therapy, targeted therapy, immunotherapy, or radiotherapy.
* Diagnosis of hematologic malignancies (e.g., leukemia, lymphoma, myeloma).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT07163169
Study Brief:
Protocol Section:
NCT07163169